CTXR

Citius Pharmaceuticals Inc

May 15 • 04:00PM ET

0.7004

-0.0196 -2.72 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN BLRX TNXP BCDA BIVI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.57	Insider Own	2.20%	Shs Outstand	27.11M	Perf Week	9.44%
Market Cap	18.99M	Forward P/E	0.25	EPS next Y	2.79	Insider Trans	0.00%	Shs Float	26.61M	Perf Month	-18.08%
Enterprise Value	22.75M	PEG	-	EPS next Q	0.39	Inst Own	6.78%	Short Float	19.78%	Perf Quarter	-8.47%
Income	-46.20M	P/S	3.39	EPS this Y	149.11%	Inst Trans	4.46%	Short Ratio	7.14	Perf Half Y	-36.62%
Sales	5.61M	P/B	0.25	EPS next Y	68.07%	ROA	-36.38%	Short Interest	5.26M	Perf YTD	-9.86%
Book/sh	2.75	P/C	4.14	EPS next 5Y	-	ROE	-75.61%	52W High	2.48 -71.76%	Perf Year	-15.40%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	16.24% 21.29%	ROIC	-74.30%	52W Low	0.57 22.88%	Perf 3Y	-97.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	37.36%	Volatility	8.70% 9.35%	Perf 5Y	-98.57%
Dividend TTM	-	EV/Sales	4.06	EPS Y/Y TTM	50.13%	Oper. Margin	-1041.44%	ATR (14)	0.07	Perf 10Y	-99.86%
Dividend Ex-Date	-	Quick Ratio	0.16	Sales Y/Y TTM	-	Profit Margin	-823.34%	RSI (14)	47.75	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.58	EPS Q/Q	25.41%	SMA20	-2.00%	Beta	1.06	Target Price	6.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-10.08%	Rel Volume	0.65	Prev Close	0.72
Employees	23	LT Debt/Eq	0.01	Earnings	Feb 13 BMO	SMA200	-32.45%	Avg Volume	737.38K	Price	0.70
IPO	Oct 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-188.39% -78.10%	Trades		Volume	480,811	Change	-2.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)